MarginsXMarginsX
Home › Markets › Health Care › PLRX

Pliant Therapeutics Inc. (PLRX)

PLRX trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$0.6932
-0.55% on the day
Market cap
$43.0M
Nano cap
Revenue · 2025
$0
Prior year not contiguous
Net income · 2025
-$149.3M

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1746473/000174647326000037/0001746473-26-000037-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerPLRX on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO year2020
SEC CIK0001746473
SEC industry codePharmaceutical Preparations
Incorporated inDE

Financials · 2025

LineValue
Revenue$0
Net income-$149.3M
Operating income-$156.4M
Net marginNeeds revenue and net income
Operating marginOperating income not reported
Revenue growthNo prior-year revenue to compare
Cash$45.4M
Total assets$225.2M
P/E (computed)Net income was not positive
P/S (computed)Needs market cap and revenue

Warning signs

Cash runway
4.8 months
$26.6M cash at September 30, 2026
Share count, 1 year
+0.9%
2025-11-01 to 2026-11-09 · +3.5% over 3 years
Going-concern doubt
No
10-Q filed November 12, 2026
Insider net buying, 12 months
-$164K
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-12
Cash and burn$26.6M cash; operating cash flow -$16.7M a quarter.Report 2026-09-30
Shares outstanding61,990,635 (2026-11-09); 61,449,385 a year earlier; 59,895,958 three years earlier.Cover page 2026-11-09
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months1 S-3/F-3 shelf filings; 0 424B5 takedownsLatest 2026-03-30
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorDeloitte & Touche LLP, San Francisco, California, United StatesPCAOB Form AP 2026-03-25
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $164K on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
Not filed-$24.4M-$17.0M$26.6M$0Needs four quarters10-Q 2026-11-12
Q2 2026
2026-06-30
Not filed-$22.4M-$12.8M$24.9M$0Needs four quarters10-Q 2026-11-12
Q1 2026
2026-03-31
Not filed-$20.0M-$19.2M$22.2M$0Needs four quarters10-Q 2026-11-12
Q4 2025
2025-12-31
Not filed-$23.6M-$17.8M$45.4M$0$010-K 2026-03-11
Q3 2025
2025-09-30
Not filed-$26.3M-$21.1M$93.7M$30.4MNeeds four quarters10-Q 2026-11-12
Q2 2025
2025-06-30
Not filed-$43.3M-$40.6M$86.8M$30.4MNeeds four quarters10-Q 2026-11-12
Q1 2025
2025-03-31
Not filed-$56.2M-$48.9M$91.9M$30.3MNeeds four quarters10-Q 2026-11-12
Q4 2024
2024-12-31
$0-$49.7M-$47.7M$71.2M$30.2M$010-K 2026-03-11

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentS-32026-03-30
Latest annual report10-K2026-03-11
Latest quarterly / interim10-Q2026-11-12
Latest current report8-K2026-11-12
Latest proxyDEFA14A2026-04-22

Source: SEC EDGAR submissions feed, 440 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-14.0%
1 month-28.0%
3 months-35.5%
Year to date-42.9%
1 year-59.5%
From 52-week high-58.5%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
IBOImpact BioMedical Inc.$4.91-4.47%$42.4M
ELTXElicio Therapeutics Inc.$1.48-1.33%$41.9M
GANXGain Therapeutics Inc.$0.9402-9.60%$41.9M
ONCYOncolytics Biotech Inc.$0.3399-8.14%$44.6M
HYFTMindWalk Holdings Corp.$0.9378-8.95%$44.6M
TLPHTalphera Inc.$0.8609-4.98%$44.7M
NMADNomad Power Solutions Inc.$2.80+19.15%$45.1M
MISTMilestone Pharmaceuticals Inc. Common Shares$0.3650-29.81%$45.4M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier